+Search query
-Structure paper
Title | Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor. |
---|---|
Journal, issue, pages | Eur J Med Chem, Vol. 131, Page 107-125, Year 2017 |
Publish date | Apr 7, 2016 (structure data deposition date) |
Authors | Liang, Q. / Chen, Y. / Yu, K. / Chen, C. / Zhang, S. / Wang, A. / Wang, W. / Wu, H. / Liu, X. / Wang, B. ...Liang, Q. / Chen, Y. / Yu, K. / Chen, C. / Zhang, S. / Wang, A. / Wang, W. / Wu, H. / Liu, X. / Wang, B. / Wang, L. / Hu, Z. / Ren, T. / Liu, Q. / Yun, C.H. / Liu, J. |
External links | Eur J Med Chem / PubMed:28315597 |
Methods | X-ray diffraction |
Resolution | 1.59 Å |
Structure data | PDB-5j87: |
Chemicals | ChemComp-N42: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE/TRANSFERASE INHIBITOR / BTK / TRANSFERASE-TRANSFERASE INHIBITOR complex |